SCHEMBL236000

SCHEMBL236000

Nc1ccn(CO)c(=O)n1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 4/20 0.51
SLC22A6 Q4U2R8 1/20 0.50
LMNA P02545 3/20 0.44
THRB P10828 1/20 0.44
MTOR P42345 1/20 0.44
MDM2 Q00987 1/20 0.44
NCOA1 Q15788 1/20 0.44
NCOA3 Q9Y6Q9 1/20 0.44
PDE3A Q14432 3/20 0.42
CACNA1F O60840 2/20 0.42
ALB P02768 2/20 0.42
MAPT P10636 2/20 0.42
CACNA1D Q01668 2/20 0.42
CACNA1S Q13698 2/20 0.42
CACNA1C Q13936 2/20 0.42
PDE4D Q08499 1/20 0.41
SLC29A1 Q99808 1/20 0.41
EP300 Q09472 7/20 0.39
CYP2D6 P10635 1/20 0.36
DNMT1 P26358 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phosphoric Acid SCHEMBL27689268 0.93 FGFR1 (0.57) FGFR1SLC22A6LMNATHRBMTOR
SCHEMBL16446911 0.88 FGFR1 (0.47) FGFR1SLC22A6LMNATHRBMTOR
Cytosine SCHEMBL16447233 0.86 FGFR1 (0.42) FGFR1SLC22A6LMNATHRBMTOR
SCHEMBL3680116 0.85 FGFR1 (0.52) FGFR1SLC22A6LMNATHRBMTOR
Glycidol SCHEMBL543441 0.84 FGFR1 (0.55) FGFR1SLC22A6LMNATHRBMTOR
SCHEMBL12261276 0.82 FGFR1 (0.47) FGFR1SLC22A6LMNATHRBMTOR
SCHEMBL20919715 0.82 FGFR1 (0.46) FGFR1SLC22A6LMNATHRBMTOR
SCHEMBL5180810 0.80 FGFR1 (0.46) FGFR1SLC22A6LMNATHRBMTOR
SCHEMBL23343373 0.80 FGFR1 (0.44) FGFR1SLC22A6LMNATHRBMTOR
SCHEMBL17372300 0.80 FGFR1 (0.44) FGFR1SLC22A6LMNATHRBMTOR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1978 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122070361-A Method for amplifying methylated DNA 辛戴克斯生物有限公司 2026-05-19 CN claimed
WO-2026087976-A1 METHOD FOR DETECTING CANCER THROUGH CELL-FREE DNA METHYLATION PATTERNS IN SUBJECT AND DIAGNOSTIC DEVICE THEREFOR STRAND LIFE SCIENCES PRIVATE LIMITED (IN) 2026-04-30 WO claimed
WO-2026090123-A1 METHODS AND COMPOSITIONS FOR MANAGING PESTS UOVO INTERNATIONAL LLC (US) 2026-04-30 WO claimed
US-12473596-B2 Delaying real-time sequencing PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (US) 2025-11-18 US claimed
US-12467082-B2 Selective oxidation of 5-methylcytosine by tet-family proteins THE CHILDREN'S MEDICAL CENTER CORPORATION 2025-11-11 US claimed
EP-4617375-A2 METHODS, COMPOSITIONS AND SYSTEMS FOR IMPROVING THE BINDING OF METHYLATED POLYNUCLEOTIDES Guardant Health, Inc. (US) 2025-09-17 EP claimed
WO-2025137620-A1 METHODS FOR HIGH QUALITY AND HIGH ACCURACY METHYLATION SEQUENCING GUARDANT HEALTH, INC. (US) 2025-06-26 WO claimed
EP-4065725-B1 METHODS, COMPOSITIONS AND SYSTEMS FOR IMPROVING THE BINDING OF METHYLATED POLYNUCLEOTIDES GUARDANT HEALTH INC (US) 2025-05-21 EP claimed
WO-2025081064-A2 THERMOPHILIC DEAMINASE AND METHODS FOR IDENTIFYING MODIFIED CYTOSINE ILLUMINA, INC. (US) 2025-04-17 WO claimed
US-20250101494-A1 METHODS FOR ANALYZING CYTOSINE METHYLATION AND HYDROXYMETHYLATION GUARDANT HEALTH, INC. 2025-03-27 US claimed
US-8206935-B2 Method of rapidly quantifying hydroxymethylated DNA LI WEIWEI (US) 2012-06-26 US claimed
US-20120064521-A1 DETECTION OF DNA HYDROXYMETHYLATION ZYMO RESEARCH CORPORATION 2012-03-15 US claimed
US-20120003663-A1 Method of rapidly quantifying hydroxymethylated DNA LI WEIWEI (US) 2012-01-05 US claimed
WO-2011127136-A1 COMPOSITION AND METHODS RELATED TO MODIFICATION OF 5-HYDROXYMETHYLCYTOSINE (5-HMC) UNIVERSITY OF CHICAGO (US) 2011-10-13 WO claimed
US-20110236894-A1 SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET-FAMILY PROTEINS IMMUNE DISEASE INSTITUTE, INC. (US) 2011-09-29 US claimed
US-7833769-B2 McrA variants and uses thereof NEW ENGLAND BIOLABS, INC. (US) 2010-11-16 US claimed
WO-2010037001-A2 SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET-FAMILY PROTEINS IMMUNE DISEASE INSTITUTE, INC. (US) 2010-04-01 WO claimed
CN-101132795-A Compounds useful in the treatment of HIV MEDIVIR AB (SE) 2008-02-27 CN claimed
WO-2003057822-A9 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY OPTIMAL PRESENTATION OF 5' ENDS HYBRIDON INC (US) 2004-07-01 WO claimed
US-4029768-A Composition for application to the animal brain for synthesis of brain components involved in the learning process, and method PENN NATHAR W 1977-06-14 US claimed